The Role of Proteinase 3 and Neutrophils in ANCA-Associated Systemic Vasculitis

QR Code

The Role of Proteinase 3 and Neutrophils in ANCA-Associated Systemic Vasculitis

None

Saved in:

Bibliographic Details
Main Author:	Abdgawad, Mohamed
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/21620
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treatment of ANCA – Associated Vasculitis
by: Katsiari, Christina G., et al.
Published: (2011)

The LAMP Story and What It Means for ANCA Positive Vasculitis in Nephrology
by: Rothe, Hansjörg
Published: (2011)

Thrombosis risk factors in ANCA-associated vasculitis
by: E. N. Kharlamova, et al.
Published: (2023-04-01)

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS
by: N. F. Frolova, et al.
Published: (2016-02-01)

Treatment With Avacopan in ANCA–Associated Vasculitis With Kidney Involvement
by: Duvuru Geetha, et al.
Published: (2025-08-01)

PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS: IN THE FOCUS OF ANCA-NEGATIVE PAUCI-IMMUNE GLOMERULONEPHRITIS
by: T. V. Beketova, et al.
Published: (2016-12-01)

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01)

Successful total hip arthroplasty in patients with anca-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2019-11-01)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
by: E. N. Vorkel, et al.
Published: (2024-12-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

New ACR/EULAR 2022 classification criteria for ANCA-associated vasculitis
by: T. V. Beketova
Published: (2023-10-01)

Review of guideline for the management of ANCA-associated vasculitis, presented in 2021 by the American College of Rheumatology/Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2021-12-01)

Role of the Matrix Metallo-Proteinases in the Cellular Re-Modeling in a Glaucoma Model System in Rat
by: Seta, Claudio De, et al.
Published: (2011)

Comorbid infections in patients with ANCA-associated systemic vasculitis: a prospective cohort study
by: M. A. Litvinova, et al.
Published: (2025-04-01)

The Role of Biological Therapies in the Management of Systemic Vasculitis
by: Vela, Paloma, et al.
Published: (2011)

THE 2016 EUROPEAN (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS
by: T. V. Beketova
Published: (2017-03-01)

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)

Clinical Burden and Costs of Anti-Neutrophil Cytoplasmic Antibody-ANCA-Associated Vasculitis: Main Findings from REDCap Registry of a University Hospital in Spain
by: Draibe J, et al.
Published: (2025-08-01)

Risk factors of poor outcomes in ANCA-associated vasculitis: a single-center study
by: Axi Age, et al.
Published: (2025-12-01)

ANCA-associated vasculitis in a 14 years-old patient: a clinical case
by: A. V. Burlutskaya, et al.
Published: (2020-10-01)

CLINICAL AND RADIOLOGICAL CHARACTERISTICS OF ANCA-ASSOCIATED VASCULITIS: 7 YEARS OF EXPERIENCE IN DIAGNOSIS AND TREATMENT
by: L. M. Kudelya, et al.
Published: (2020-03-01)

Diverse Activities for Proteinases in the Pathogenesis of Chronic Obstructive Pulmonary Disease
by: Kelly, Emer, et al.
Published: (2012)

ANCA Diagnostics in Clinical Practice: New Developments
by: Damoiseaux, Jan, et al.
Published: (2011)

Use of Avacopan as a Steroid-Sparing Medication in ANCA-associated Vasculitis Patients with Renal Impairment
by: Mitchell Salke, et al.
Published: (2025-06-01)

Pulmonary and Renal Predictors of Mortality in ANCA-Associated Vasculitis: A Regional Experience from Türkiye
by: Dilara Bulut Gökten, et al.
Published: (2025-06-01)

Late-onset neutropenia induced by anti-B cell therapy with rituximab in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2022-06-01)

Starting working meeting on «Russian Register of Patients with ANCA-Associated Systemic Vasculitis» (28 April, 2014, Moscow)
by: Issue Editor
Published: (2014-06-01)

Covid-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)
by: T. V. Beketova, et al.
Published: (2020-09-01)

Biologic Agents for the Treatment of Systemic Vasculitis
by: Sfriso, P., et al.
Published: (2011)

Audiovestibular Manifestations in Systemic Vasculitis: An Update
by: Amor-Dorado, Juan Carlos, et al.
Published: (2011)

Aortitis and aortic aneurysm in systemic vasculitis
by: García-Martínez, Ana, et al.
Published: (2011)

Recent Advances in the Research and Development of Alpha-1 Proteinase Inhibitor for Therapeutic Use
by: Karnaukhova, Elena
Published: (2012)

Neutrophil Gelatinase Associated Lipocalin: Structure, Function and Role in Human Pathogenesis
by: Chakraborty, Subhankar, et al.
Published: (2011)

THE VALUE OF THE RUSSIAN NATIONAL REGISTRY OF PATIENTS WITH ANCA-ASSOCIATED SYSTEMIC VASCULITIS AS AN INNOVATIVE TOOL OF PERSONALIZED INDUCTION AND MAINTENANCE THERAPY
by: T. V. Beketova
Published: (2016-12-01)

Histopathology of Cutaneous Vasculitis
by: Chen, Ko-Ron
Published: (2011)

Endothelial Cells and Vasculitis
by: Djordjević, Vidosava B., et al.
Published: (2011)

Drug-Induced Vasculitis
by: Radić, Mislav
Published: (2011)

Bypass for the Treatment of Vasculitis Affecting the Central Nervous System
by: Rodríguez-Hernández, Ana, et al.
Published: (2011)

Atherosclerosis in ANCA-associated systemic vasculitides
by: E I Kuznetsova, et al.
Published: (2012-06-01)